Calcium and vitamin D for corticosteroid-induced osteoporosis
- PMID: 10796394
- PMCID: PMC7046131
- DOI: 10.1002/14651858.CD000952
Calcium and vitamin D for corticosteroid-induced osteoporosis
Abstract
Objectives: To assess the effects of calcium and vitamin D compared to calcium alone or placebo in the prevention of bone loss in patients taking systemic corticosteroids.
Search strategy: We searched the Cochrane Musculoskeletal trials register, Cochrane Controlled Trials Register, EMBASE and Medline up to 1996. We also conducted a hand search of abstracts from various scientific meetings and reference lists of selected trials.
Selection criteria: All randomized trials comparing calcium and vitamin D to calcium alone or placebo in patients taking systemic corticosteroids.
Data collection and analysis: Data was abstracted from trials by two investigators. Methodological quality was assessed in a similar manner. Analysis was performed using fixed effects models.
Main results: Five trials were included, with 274 patients. The analysis was performed at two years after starting calcium and vitamin D. There was a significant weighted mean difference (WMD) between treatment and control groups in lumbar (WMD 2.6 (95% CI 0.7, 4.5), and radial bone mineral density (WMD 2.5 (95% CI 0.6, 4.4). The other outcome measures (femoral neck bone mass, fracture incidence, biochemical markers of bone resorption) were not significantly different.
Reviewer's conclusions: This meta-analysis demonstrated a clinically and statistically significant prevention of bone loss at the lumbar spine and forearm with vitamin D and calcium in corticosteroid treated patients. Because of low toxicity and cost all patients being started on corticosteroids should receive prophylactic therapy with calcium and vitamin D.
Conflict of interest statement
None known
Figures
Similar articles
-
Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.Cochrane Database Syst Rev. 2000;2000(2):CD001983. doi: 10.1002/14651858.CD001983. Cochrane Database Syst Rev. 2000. PMID: 10796457 Free PMC article. Review.
-
Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.Calcif Tissue Int. 2005 Mar;76(3):176-86. doi: 10.1007/s00223-004-0005-4. Epub 2005 Feb 7. Calcif Tissue Int. 2005. PMID: 15692726
-
Bisphosphonates for steroid induced osteoporosis.Cochrane Database Syst Rev. 2000;(2):CD001347. doi: 10.1002/14651858.CD001347. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2016 Oct 05;10:CD001347. doi: 10.1002/14651858.CD001347.pub2. PMID: 10796432 Updated. Review.
-
Interventions for preventing bone disease in kidney transplant recipients.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005015. doi: 10.1002/14651858.CD005015.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005015. doi: 10.1002/14651858.CD005015.pub3. PMID: 15846740 Updated. Review.
-
Calcium and vitamin D therapy in corticosteroid-induced bone loss: what is the evidence?Calcif Tissue Int. 1999 Oct;65(4):332-6. doi: 10.1007/s002239900707. Calcif Tissue Int. 1999. PMID: 10485987 Review.
Cited by
-
Ten tips on how to assess bone health in patients with chronic kidney disease.Clin Kidney J. 2024 Apr 15;17(5):sfae093. doi: 10.1093/ckj/sfae093. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38817914 Free PMC article.
-
Long non-coding RNA-NONMMMUT004552.2 regulates the unloading-induced bone loss through the miRNA-15b-5p/Syne1 in mice.NPJ Microgravity. 2024 Mar 23;10(1):37. doi: 10.1038/s41526-024-00382-8. NPJ Microgravity. 2024. PMID: 38521778 Free PMC article.
-
Utilization of Waste Eggshell Powder as an Excipient for Vitamin D3 Tablet Preparation.ACS Omega. 2024 Jan 11;9(3):3980-3987. doi: 10.1021/acsomega.3c08416. eCollection 2024 Jan 23. ACS Omega. 2024. PMID: 38284045 Free PMC article.
-
The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline.Br J Haematol. 2024 Apr;204(4):1178-1192. doi: 10.1111/bjh.19273. Epub 2024 Jan 21. Br J Haematol. 2024. PMID: 38247115 Free PMC article. No abstract available.
-
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.J Orthop Surg Res. 2023 Jun 22;18(1):447. doi: 10.1186/s13018-023-03920-4. J Orthop Surg Res. 2023. PMID: 37349750 Free PMC article.
References
References to studies included in this review
Adachi 1996 {published data only}
-
- Adachi JD, Bensen WB, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, Tugwell P, Gordon M, Steele M, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: A 3 year followup. J Rheumatol 1996;23(6):(pp99 5‐1000). - PubMed
Buckley 1996 {published data only}
-
- Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Calcium and Vitamin D3 supplementation prevents bone loss in the spine secondary to low‐dose corticosteroids in patients with rheumatoid arthritis. A randomized, double‐blind, placebo‐controlled trial. Ann Intern Med 1996;126:961‐68. - PubMed
Di Munno 1989 {published data only}
-
- Munno O, Beghe F, Favini P, Giuseppe P, Pontrandolfo A, Occhipinti G, Pasero G. Prevention of glucocorticoid‐induced osteopenia: effect of oral 25‐hydroxyvitamin D and calcium. Clin Rheumatol 1989;8(2):202‐7. - PubMed
Dykman 1984 {published data only}
-
- Dykman TR, Haralson KM, Gluck OS, Murphy WA, Teitelbaum SL, Hahn TJ, Hahn BH. Effect of oral 1,25‐dihydroxyvitamin D and calcium on glucocorticoid‐induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1984;27(12):1336‐43. - PubMed
Sambrook 1993 {published data only}
-
- Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993;328(24). - PubMed
References to studies excluded from this review
Braun 1983 {published data only}
-
- Braun JJ, Birkenhager‐Frenkel DH, Rietveld AH, Juttmann JR, Visser TJ, Birkenhager JC. Influence of 1 alph‐(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study. Clin En docrinol 1983;19(2):265‐73. - PubMed
Hahn 1979 {published data only}
Vogelsang 1995 {published data only}
-
- Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long‐term oral vitamin D supplementation. European Journal of Gastroenterology & Hepatology 1995;7:609‐14. - PubMed
Additional references
Dickersin 1994
Jadad 1996
-
- Jadad A, Moore A, Carrol D, et al. Assessing the quality of reports of randomized trials: is blinding necessary?. Control Clin Trial 1996;17:1‐12. - PubMed
Petitti 1994
-
- Petitti D. Meta‐analysis, decision analysis, and cost‐effectiveness analysis: methods for quantitative synthesis in medicine. 90‐114.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
